Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23953)

• Formulation Name: Dabrafenib Mesylate eq 75mg base capsule
• Company: Novartis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dabrafenib	(DMX6OE3)	Melanoma	2C30	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Haematite red	(E00236)	14833	Colorant
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent